158 related articles for article (PubMed ID: 2479357)
1. Nucleolar organizer regions in transitional cell tumors of the bladder.
Cairns P; Suarez V; Newman J; Crocker J
Arch Pathol Lab Med; 1989 Nov; 113(11):1250-2. PubMed ID: 2479357
[TBL] [Abstract][Full Text] [Related]
2. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder.
Mansour P; Crocker J; Newman J
Arch Pathol Lab Med; 1990 Dec; 114(12):1261. PubMed ID: 1701296
[TBL] [Abstract][Full Text] [Related]
3. [Nucleolar organizer region in bladder cancer. Relationship with histologic grade, stage, and prognosis].
Rivera P; Roa I
Actas Urol Esp; 1994 Mar; 18(3):204-6. PubMed ID: 8036947
[TBL] [Abstract][Full Text] [Related]
4. Nucleolar organizer region in transitional cell carcinoma of the bladder.
Pisac VP; Krizanac S; Andelinović S
Acta Med Croatica; 1997; 51(2):83-6. PubMed ID: 9204592
[TBL] [Abstract][Full Text] [Related]
5. AgNORs in benign, borderline and transitional cell neoplasms of the urinary bladder.
Misra V; Mukherjee J; Gupta SC; Tandon S; Gupta AK
APMIS; 1998 Oct; 106(10):987-92. PubMed ID: 9833702
[TBL] [Abstract][Full Text] [Related]
6. [Significance of AgNOR analysis of urothelial carcinomas].
Helpap B; Loesevitz L
Verh Dtsch Ges Pathol; 1993; 77():222-5. PubMed ID: 7511285
[TBL] [Abstract][Full Text] [Related]
7. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
8. [Alterations of nucleoli and nucleolar organizers in proliferative cystitis and transitional cell carcinoma of the urinary bladder].
Romanenko AM; Nosov AT; Bazalitskaia SV; Sabri Abdel' Maliak S; Adne ZhZh
Arkh Patol; 1992; 54(7):14-20. PubMed ID: 1471934
[TBL] [Abstract][Full Text] [Related]
9. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
10. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa.
Johnson GC; Miller MA; Ramos-Vara JA
J Vet Diagn Invest; 1995 Jan; 7(1):127-36. PubMed ID: 7779947
[TBL] [Abstract][Full Text] [Related]
11. [Nucleolar organizers in superficial bladder tumors. Prognostic analysis of 37 observations].
Clement T; Visseaux-Coletto B; Adnet JJ; Ploton D; Lardennois B
Prog Urol; 1991 Apr; 1(2):216-29. PubMed ID: 1844824
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
Akpolat I; Bariş YS; Yilmaz AF; Bakirtaş M; Saylik A; Karagöz F; Kandemir B
Neoplasma; 1998; 45(6):365-8. PubMed ID: 10210109
[TBL] [Abstract][Full Text] [Related]
13. [In situ and invasive cancer of the gallbladder: nucleolar organizer regions].
Roa I; Araya JC; Wistuba I; De Aretxabala X; Mauriz A; Cea M
Rev Med Chil; 1990 Apr; 118(4):369-72. PubMed ID: 1723212
[TBL] [Abstract][Full Text] [Related]
14. Two-dimensional agnor evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total agnor area/nucleus area per cell.
Cucer N; Imamoglu N; Tozak H; Demirtas H; Sarac F; Tatlisen A; Oztürk F
Micron; 2007; 38(6):674-9. PubMed ID: 17011198
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar organizer regions in bladder cancer: application to urinary cytology.
Masuda M; Nagamoto A; Hirokawa M; Takano Y; Shuin T
Urology; 1994 Aug; 44(2):194-8. PubMed ID: 8048194
[TBL] [Abstract][Full Text] [Related]
16. Value of the silver-stained nucleolar organizer regions technique in the differentiation between benign and malignant lesions in urine cytology.
Hussein HG; Ali HH
Saudi Med J; 2009 May; 30(5):719-21. PubMed ID: 19417979
[No Abstract] [Full Text] [Related]
17. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
Helpap B; Loesevitz L; Bulatko A
Virchows Arch; 1994; 425(3):265-9. PubMed ID: 7812512
[TBL] [Abstract][Full Text] [Related]
18. [Argentophilic nucleolar organizers and prognosis for patients with surface and locally advanced transitional cell cancer of the urinary bladder].
Korneev IA
Urologiia; 2005; (1):5-9. PubMed ID: 15776823
[TBL] [Abstract][Full Text] [Related]
19. Assessment of argyrophilic nucleolar organizer region quantification in benign and malignant bone tumors.
Clohisy JC; Schajowicz F; Vaziri DM; McDonald DJ; Connolly TJ; Sotelo-Avila C; Betts JE
Clin Orthop Relat Res; 1995 Jan; (310):229-36. PubMed ID: 7641444
[TBL] [Abstract][Full Text] [Related]
20. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
Skopelitou A; Korkolopoulou P; Papanicolaou A; Christodoulou P; Thomas-Tsagli E; Pavlakis K
Eur Urol; 1992; 22(3):235-40. PubMed ID: 1361436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
